Resources

David Joffe, BSPharm, CDE, Editor-in-chief, Diabetes In Control The Endocrine Society has published a new set of recommendations on the definition of endocrine-disrupting chemicals (EDC) and screening programs for such chemicals.

Medtronic’s Enlite CGM Sensor This sensor was approved in Europe in April 2011, and the FDA is still waiting for an additional study by Medtronic before approving the new sensor in the U.S. According to Medtronic, Enlite combines greater comfort with improved glucose sensor performance in both overall accuracy and …

Metformin might offer a therapy for nervous system damage…. 

Duke University Medical Center researchers have found protective, anti-diabetic functions for a hormone that, like insulin, is produced by the islet cells of the pancreas…. 

Predictive factors for type 2 diabetes remission following gastric bypass include insulin use and preoperative glucose disposition index….

Two-year results suggest that the use of the DPP-4 inhibitor linagliptin is as effective as glimepiride in treating diabetic patients who are inadequately controlled with metformin…. 

Diabetic patients with non-ST-segment elevation ACS appear to benefit from early invasive treatment, a benefit that has not been observed in low-risk nondiabetic patients…. 

Serum apoliproteins are linked to markers of systemic, retinal microvascular dysfunction in diabetes….

This exercise, which just about everyone can do, can lower risk for diabetes and reduce weight gain and improve cardiovascular health…. 

Gevokizumab, a new diabetes drug, may improve fluctuations in blood sugar and reduce inflammation in patients with type 2 diabetes….